can i switch from tirzepatide to semaglutide Tirzepatide? Maintenance therapy on semaglutide or

The emerging lesson from obesity medicine is that the future lies not in finding a single "best" drug, but in understanding which treatment is most likely to work for which patient

[PMC free article] [PubMed] [Google Scholar] 101.Lee YC, Cohet C, Yang YC, Stayner L, Hashibe M, Straif K

Understanding peptide safety and risks before starting any protocol is essential regardless of which provider you choose

This is the first GLP-1 pill approved specifically for weight loss, providing another option for patients who prefer not to use injections

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound)

Combining strong GH secretagogues with GLP-1 agonists creates opposing forces on glucose metabolism